Systematic ReviewSystematic Review
Open Access

Overview of hypertension in Saudi Arabia

A systematic review and meta-analysis

Sulaiman A. Alshammari, Abdullah S. Alshammari, Hotoon S. Alshammari and Shaik S. Ahamed
Saudi Medical Journal October 2023, 44 (10) 951-964; DOI: https://doi.org/10.15537/smj.2023.44.10.20230178

References

  1. 1.↵
    1. Mohammadian Khonsari N,
    2. Shahrestanaki E,
    3. Ejtahed H-S,
    4. Djalalinia S,
    5. Sheidaei A,
    6. Hakak-Zargar B, et al.
    Long-term trends in hypertension prevalence, awareness, treatment, and control rate in the middle east and north africa: A systematic review and meta-analysis of 178 population-based studies. Curr Hypertens Rep 2021; 23: 1–26.
    OpenUrl
  2. 2.↵
    1. Mills KT,
    2. Stefanescu A,
    3. He J.
    The global epidemiology of hypertension. Nat Rev Nephrol 2020; 16: 223–237.
    OpenUrlPubMed
  3. 3.↵
    1. Hahad O,
    2. Schmitt VH,
    3. Arnold N,
    4. Keller K,
    5. Prochaska JH,
    6. Wild PS, et al.
    Chronic cigarette smoking is associated with increased arterial stiffness in men and women: Evidence from a large population-based cohort. Clin Res Cardiol 2023; 112: 270–284.
    OpenUrl
  4. 4.↵
    1. Mouhtadi BB,
    2. Kanaan RMN,
    3. Iskandarani M,
    4. Rahal MK,
    5. Halat DH. Prevalence
    , awareness, treatment, control and risk factors associated with hypertension in Lebanese adults: A cross sectional study. Glob Cardiol Sci Pract 2018; 2018: 6.
    OpenUrl
  5. 5.↵
    1. Mamdouh H,
    2. Alnakhi WK,
    3. Hussain HY,
    4. Ibrahim GM,
    5. Hussein A,
    6. Mahmoud I, et al.
    Prevalence and associated risk factors of hypertension and pre-hypertension among the adult population: Findings from the Dubai household survey, 2019. BMC Cardiovasc Disord 2022; 22: 18.
    OpenUrlPubMed
  6. 6.↵
    1. Valenzuela PL,
    2. Carrera-Bastos P,
    3. Gálvez BG,
    4. Ruiz-Hurtado G,
    5. Ordovas JM,
    6. Ruilope LM, et al.
    Lifestyle interventions for the prevention and treatment of hypertension. Nat Rev Cardiol 2021; 18: 251–275.
    OpenUrlCrossRef
  7. 7.↵
    1. Al-Jawaldeh A,
    2. Taktouk M,
    3. Chatila A,
    4. Naalbandian S,
    5. Al-Thani A-AM,
    6. Alkhalaf MM, et al.
    Salt reduction initiatives in the eastern mediterranean region and evaluation of progress towards the 2025 global target: A systematic review. Nutrients 2021; 13: 2676.
    OpenUrl
  8. 8.↵
    1. Murphy A,
    2. Palafox B,
    3. Walli-Attaei M,
    4. Powell-Jackson T,
    5. Rangarajan S,
    6. Alhabib KF, et al.
    The household economic burden of non-communicable diseases in 18 countries. BMJ Glob Health 2020; 5: e002040.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Zhou B,
    2. Carrillo-Larco RM,
    3. Danaei G,
    4. Riley LM,
    5. Paciorek CJ,
    6. Stevens GA, et al.
    Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398: 957–980.
    OpenUrlPubMed
  10. 10.↵
    1. Zhou B,
    2. Danaei G,
    3. Stevens GA,
    4. Bixby H,
    5. Taddei C,
    6. Carrillo-Larco RM, et al.
    Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet 2019; 394: 639–651.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Muntner P,
    2. Miles MA,
    3. Jaeger BC,
    4. Hannon Iii L,
    5. Hardy ST,
    6. Ostchega Y, et al.
    Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020. Hypertension 2022; 79: 1971–1980.
    OpenUrlPubMed
  12. 12.↵
    1. Carey RM,
    2. Moran AE,
    3. Whelton PK.
    Treatment of hypertension: A review. Jama 2022; 328: 1849–1861.
    OpenUrl
  13. 13.↵
    1. Haddaway NR,
    2. Page MJ,
    3. Pritchard CC,
    4. McGuinness LA.
    PRISMA2020: An R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev 2022; 18: e1230.
    OpenUrlCrossRef
  14. 14.↵
    1. Yusufali A,
    2. Bazargani N,
    3. Bin Belaila BA,
    4. Suhail AM,
    5. Shuri HH,
    6. Agrawal A, et al.
    May Measurement Month 2018: An analysis of blood pressure screening results from United Arab Emirates. Eur Heart J Suppl 2020; 22: H128–H131.
    OpenUrl
  15. 15.↵
    1. Khader Y,
    2. Batieha A,
    3. Jaddou H,
    4. Rawashdeh SI,
    5. El-Khateeb M,
    6. Hyassat D, et al.
    Hypertension in Jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens 2019; 2019: 3210617.
    OpenUrl
  16. 16.↵
    1. Kang S-H,
    2. Kim S-H,
    3. Cho JH,
    4. Yoon C-H,
    5. Hwang S-S,
    6. Lee H-Y, et al.
    Prevalence, awareness, treatment, and control of hypertension in Korea. Sci Rep 2019; 9: 10970.
    OpenUrlCrossRef
  17. 17.↵
    1. Odili AN,
    2. Chori BS,
    3. Danladi B,
    4. Nwakile PC,
    5. Okoye IC,
    6. Abdullahi U, et al.
    Prevalence, awareness, treatment and control of hypertension in Nigeria: data from a nationwide survey 2017. Glob Heart 2020; 15: 47.
    OpenUrl
  18. 18.↵
    1. Chow ZY,
    2. Jun SM,
    3. Ching SM,
    4. Tan CH,
    5. Lee KW,
    6. Devaraj NK, et al.
    Prevalence, awareness and control of hypertension in Malaysia 1980–2017: A systematic review and meta-analysis. BioRxiv 2019: 625004.
  19. 19.↵
    1. Lamelas P,
    2. Diaz R,
    3. Orlandini A,
    4. Avezum A,
    5. Oliveira G,
    6. Mattos A, et al.
    Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries. J Hypertens 2019; 37: 1813–1821.
    OpenUrl
  20. 20.↵
    1. Ab Majid NL,
    2. Omar MA,
    3. Khoo YY,
    4. Mahadir Naidu B,
    5. Ling Miaw Yn J,
    6. Rodzlan Hasani WS, et al.
    Prevalence, awareness, treatment and control of hypertension in the Malaysian population: Findings from the national health and morbidity survey 2006–2015. J Hum Hypertens 2018; 32: 617–624.
    OpenUrl
  21. 21.↵
    1. Li W,
    2. Fang W,
    3. Huang Z,
    4. Wang X,
    5. Cai Z,
    6. Chen G, et al.
    Association between age at onset of overweight and risk of hypertension across adulthood. Heart 2022; 108: 683–688.
    OpenUrlAbstract/FREE Full Text
  22. 22.
    1. Siregar RJ,
    2. Siregar RA.
    Factors which influence incident hypertension on pre-elderly. IJPHE 2022; 1: 117–121.
    OpenUrl
  23. 23.↵
    1. Tsuchihashi T.
    Dietary salt intake in Japan-past, present, and future. Hypertens Res 2022; 45: 748–757.
    OpenUrl
  24. 24.↵
    1. Atik F,
    2. Aktas G,
    3. Kocak MZ,
    4. Erkus E,
    5. Savli H.
    Analysis of the factors related to the blood pressure control in hypertension. J Coll Physicians Surg Pak 2018; 28: 423–426.
    OpenUrl
  25. 25.↵
    1. Kurtkulagi O,
    2. Aktas G,
    3. Bilgin S,
    4. Meryem Atak B,
    5. Taslamacioglu Duman T,
    6. Emin D.
    Combined antihypertensive treatment is better than mono-therapy in hypertensive patients. Neth J Med 2020; 78: 239–243.
    OpenUrl
  26. 26.↵
    1. Aktas G,
    2. Khalid A,
    3. Kurtkulagi O,
    4. Duman TT,
    5. Bilgin S,
    6. Kahveci G, et al.
    Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: A cross-sectional cohort study. Postgrad Med 2022; 134: 297–302.
    OpenUrl
  27. 27.↵
    1. Kurtkulagi O,
    2. Aktas G,
    3. Taslamacioglu Duman T,
    4. Bilgin S,
    5. Atak Tel BM,
    6. Kahveci G.
    Correlation between serum triglyceride to HDL cholesterol ratio and blood pressure in patients with primary hypertension. Precision Medical Sciences 2022; 11: 100–105.
    OpenUrl
  28. 28.↵
    1. Li Y,
    2. Geng X,
    3. Wang H,
    4. Cheng G,
    5. Xu S.
    CTRP9 ameliorates pulmonary arterial hypertension through attenuating inflammation and improving endothelial cell survival and function. J Cardiovasc Pharmacol 2016; 67: 394–401.
    OpenUrl
  29. 29.↵
    1. Civil C,
    2. Balci B,
    3. Aktas G.
    The importance of using automatic blood pressure measuring devices in hypertension patients. Journal of Bionic Memory 2022; 2: 79–86.
    OpenUrl
  30. 30.↵
    1. Chia Y-C,
    2. Ching SM,
    3. Chew BN,
    4. Devaraj NK,
    5. Siti Suhaila MY,
    6. Tay CL, et al.
    May measurement month 2017 blood pressure screening: Findings from Malaysia-South-East Asia and Australasia. Eur Heart J Suppl 2019; 21: D77–D79.
    OpenUrl
  31. 31.
    1. Osman A,
    2. Al Nozha M.
    Risk factors of coronary artery disease in different regions of Saudi Arabia. East Mediterr Health J 2000; 6: 465–474.
    OpenUrlPubMed
  32. 32.
    1. Al-Nozha MM,
    2. Abdullah M,
    3. Arafah MR,
    4. Khalil MZ,
    5. Khan NB,
    6. Al-Mazrou YY, et al.
    Hypertension in Saudi Arabia. Saudi Med J 2007; 28: 77–84.
    OpenUrlAbstract/FREE Full Text
  33. 33.
    1. Saeed AA,
    2. Al-Hamdan NA,
    3. Bahnassy AA,
    4. Abdalla AM,
    5. Abbas MA,
    6. Abuzaid LZ. Prevalence
    , awareness, treatment, and control of hypertension among Saudi adult population: A national survey. Int J Hypertens 2011; 2011: 174135.
    OpenUrlPubMed
  34. 34.
    1. Khoja AT,
    2. Aljawadi MH,
    3. Al-Shammari SA,
    4. Mohamed AG,
    5. Al-Manaa HA,
    6. Morlock L, et al.
    The health of Saudi older adults; results from the Saudi national survey for elderly health (SNSEH) 2006-2015. Saudi Pharm J 2018; 26: 292–300.
    OpenUrl
  35. 35.
    1. El Bcheraoui C,
    2. Memish ZA,
    3. Tuffaha M,
    4. Daoud F,
    5. Robinson M,
    6. Jaber S, et al.
    Hypertension and its associated risk factors in the Kingdom of Saudi Arabia, 2013: A national survey. Int J Hypertens 2014; 2014: 564679.
  36. 36.
    1. Al-Daghri NM,
    2. Al-Attas OS,
    3. Alokail MS,
    4. Alkharfy KM,
    5. Yousef M,
    6. Sabico SL, et al.
    Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): A decade of an epidemic. BMC Med 2011; 9: 76.
    OpenUrlCrossRefPubMed
  37. 37.
    1. Abolfotouh MA,
    2. Abu-Zeid HAH,
    3. Aziz MA,
    4. Alakija W,
    5. Mahfouz AA,
    6. Bassuni WA.
    Prevalence of hypertension in south-western Saudi Arabia. East Mediterr Health J 1996; 2: 211–218.
    OpenUrl
  38. 38.
    1. Al-Baghli NA,
    2. Al-Turki KA,
    3. Al-Ghamdi AJ,
    4. El-Zubaier AG,
    5. Al-Baghli FA,
    6. Bohlaiqa NH.
    Control of hypertension in eastern Saudi Arabia: Results of screening campaign. J Family Community Med 2009; 16: 19–25.
    OpenUrl
  39. 39.
    1. Elkhalifa AM,
    2. Kinsara AJ,
    3. Almadani DA.
    Prevalence of hypertension in a population of healthy individuals. Med Princ Pract 2011; 20: 152–155.
    OpenUrlPubMed
  40. 40.
    1. Alsuwaida A,
    2. Alghonaim M.
    Gender disparities in the awareness and control of hypertension. Clin Exp Hypertens 2011; 33: 354–357.
    OpenUrlPubMed
  41. 41.
    1. Gutierrez J,
    2. Alloubani A,
    3. Mari M,
    4. Alzaatreh M.
    Cardiovascular disease risk factors: Hypertension, diabetes mellitus and obesity among Tabuk citizens in Saudi Arabia. Open Cardiovasc Med J 2018; 12: 41–49.
    OpenUrl
  42. 42.
    1. Saquib N,
    2. Saquib J,
    3. Alhadlag A,
    4. Albakour MA,
    5. Aljumah B,
    6. Sughayyir M, et al.
    Chronic disease prevalence among elderly Saudi men. Int J Health Sci 2017; 11: 11–16.
    OpenUrl
  43. 43.
    1. Mirza AA,
    2. Elmorsy SA.
    Diagnosis and control of hypertension as indicators of the level of awareness among relatives of medical students in Saudi Arabia. High Blood Press Cardiovasc Prev 2016; 23: 123–132.
    OpenUrl
  44. 44.
    1. Ahmed HG,
    2. Ginawi IA,
    3. Haridi HK,
    4. Eltom FM,
    5. Al-hazimi AM.
    Distribution of CKD and hypertension in 13 towns in Hail region, KSA. Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology 2014; 6: 39–45.
    OpenUrl
  45. 45.
    1. Alkahtani SA,
    2. Al-Hariri MT.
    Hypertension and employee’s health: A cross-sectional analysis in private sector at Eastern province, Saudi Arabia. Saudi J Health Sci 2016; 5: 61–66.
    OpenUrl
  46. 46.
    1. Alyabsi M,
    2. Gaid R,
    3. Alqunaibet A,
    4. Alaskar A,
    5. Mahmud A,
    6. Alghamdi J.
    Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals. BMJ Open 2020; 10: e041973.
    OpenUrl
  47. 47.
    1. Al-Mohaissen M,
    2. Al-Obaid Q,
    3. AlGhamdi W,
    4. Al-Alyani H,
    5. Dahman S,
    6. Al-Wahhabi N, et al.
    Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline on the prevalence of hypertension in young Saudi women. East Mediterr Health J 2020; 26(4): 426–434.
    OpenUrl
  48. 48.
    1. Alanazi AMJ,
    2. Yusef Muhana A,
    3. Tariq Hulayyil A,
    4. Bader Arar Shadad A,
    5. Abdulaziz Mofareh Murid A,
    6. Amjed Naeem A, et al.
    Prehypertension and Hypertension in Medical Students of Northern Border University in Arar, Saudi Arabia. Egyptian Journal of Hospital Medicine 2018; 70: 33–38.
    OpenUrl
  49. 49.
    1. Baig M,
    2. Gazzaz ZJ,
    3. Gari MA,
    4. Al-Attallah HG,
    5. Al-Jedaani KS,
    6. Mesawa AT, et al.
    Prevalence of obesity and hypertension among University students’ and their knowledge and attitude towards risk factors of Cardiovascular Disease (CVD) in Jeddah, Saudi Arabia. Pak J Med Sci 2015; 31: 816–820.
    OpenUrl
  50. 50.
    1. Madkhali A,
    2. Sabai A,
    3. Himli E,
    4. Mathkoor S,
    5. Gohal T,
    6. Suwaydi S, et al.
    Prevalence of pre-hypertension and hypertension among secondary school students in Samtah city, Saudi Arabia. 2022.
  51. 51.
    1. Rehmani R,
    2. Elzubair AG,
    3. Al Maani M,
    4. Chaudary IY,
    5. Al Qarni A,
    6. Khasshogi T, et al.
    Population-based health survey in eastern region of Saudi Arabia. East Mediterr Health J 2013; 19: 417–425.
    OpenUrl
  52. 52.
    1. Elzubier AG,
    2. Al-Shahri MA.
    Drug control of hypertension in primary health care centers-registered patients, Al-Khobar, Saudi Arabia. J Family Community Med 1997; 4: 47–53.
    OpenUrl
  53. 53.
    1. Al-Tuwijri AA,
    2. Al-Rukban MO.
    Hypertension control and co-morbidities in primary health care centers in Riyadh. Ann Saudi Med 2006; 26: 266–271.
    OpenUrlPubMed
  54. 54.
    1. Al-Rukban MO,
    2. Al-Sughair AM,
    3. Al-Bader BO,
    4. Al-Tolaihi BA.
    Management of hypertensive patients in primary health care setting, auditing the practice. Saudi Med J 2007; 28: 85–90.
    OpenUrlAbstract/FREE Full Text
  55. 55.
    1. Safdar O,
    2. AlJehani R,
    3. Aljuhani M,
    4. AlGhamdi H,
    5. Asiri A,
    6. AlGhofaily O, et al.
    Hypertension in pediatric patients admitted to inpatient ward at King Abdulaziz University Hospital in Saudi Arabia: Prevalence, causes, and outcomes. J Family Med Prim Care 2020; 9: 4031–4038.
    OpenUrl
  56. 56.
    1. AlQuaiz AM,
    2. Kazi A,
    3. Alodhayani AA,
    4. Almeneessier A,
    5. AlHabeeb KM,
    6. Siddiqui AR.
    Age and gender differences in the prevalence of chronic diseases and atherosclerotic cardiovascular disease risk scores in adults in Riyadh city, Saudi Arabia. Saudi Med J 2021; 42: 526–536.
    OpenUrlAbstract/FREE Full Text
  57. 57.
    1. Kalantan KA,
    2. Mohamed AG,
    3. Al-Taweel AA,
    4. Abdul Ghani HM.
    Hypertension among attendants of primary health care centers in Al-Qassim region, Saudi Arabia. Saudi Med J 2001; 22: 960–963.
    OpenUrlAbstract/FREE Full Text
  58. 58.
    1. Al-Qahtani AM.
    Prevalence and Determinants of Blood Pressure Control Among Hypertensive Patients in Primary Care Centers, Najran, Saudi Arabia. Biomed Pharmacol J 2018; 11: 821–825.
    OpenUrl
  59. 59.
    1. Ahmed ME,
    2. El-Awad IB.
    Blood pressure control and target organ complications among hypertensive patients in southern Saudi Arabia. East Mediterr Health J 2001; 7: 689–696.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords